In overweight or obesity without diabetes, weekly semaglutide vs. daily liraglutide increased weight loss at 68 wk.
rct · Level II
Where this comes from
- Record sourced from PubMed, PMID 35500264.
- Also identified by DOI 10.7326/J22-0023.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Rubino DM, Greenway FL, Khalid U, et al. <b>Effect of weekly subcutaneous semaglutide vs daily liraglutide on body weight in adults with overweight or obesity without diabetes: the STEP 8 randomized clinical trial.</b> JAMA. 2022;327:138-50. 35015037.
Medical subject headings
- Diabetes Mellitus
- Diabetes Mellitus, Type 2